Yes, foreign manufacturers can obtain GMP certification in China. They must comply with Chinese Good Manufacturing Practices (GMP) standards, undergo inspections by Chinese regulatory authorities, and submit necessary documentation. Successful compliance ensures their products meet quality and safety standards required for the... Read More
Drug registration in China involves several fees, including application fees, technical review fees, and inspection fees. These cover the costs of dossier evaluation, clinical trial assessments, and Good Manufacturing Practice (GMP) inspections. Fees vary based on drug type, such as new drugs,... Read More
Approval for a clinical trial in China typically takes around 60 working days after submission to the National Medical Products Administration (NMPA). However, the timeline can vary depending on the complexity of the trial and the completeness of the application. Pre-submission consultations... Read More
Yes, documentation submitted in a China Drug Master File (DMF) must be in Chinese. If original documents are in another language, certified Chinese translations are required. This ensures compliance with the National Medical Products Administration (NMPA) regulations for drug registration and review... Read More
For medical device registration in Taiwan, required documents include a completed application form, device description, quality system documentation, clinical data, labeling and packaging information, proof of compliance with relevant standards, and a Certificate of Free Sale from the country of origin. Additional... Read More
In Korea, drug audits include Good Manufacturing Practice (GMP) inspections, Good Clinical Practice (GCP) audits, and Good Laboratory Practice (GLP) assessments. These audits ensure compliance with regulatory standards, quality control, and safety protocols in pharmaceutical manufacturing, clinical trials, and laboratory testing, respectively. Read More
For drug registration in Korea, required documents include a completed application form, Certificate of Pharmaceutical Product (CPP), Good Manufacturing Practice (GMP) certificate, clinical trial data, stability test data, product labeling, and detailed manufacturing and quality control information. Additional documents may be needed... Read More
To prepare for a drug GMP audit in China, a company should ensure compliance with local regulations, maintain accurate and up-to-date documentation, conduct internal audits, train staff on regulatory requirements, and establish clear communication with Chinese regulatory authorities. Engaging local experts can... Read More
GMP inspections in China are typically conducted every five years. However, the frequency can vary based on the risk profile of the manufacturer, previous inspection outcomes, and regulatory updates. High-risk facilities may face more frequent inspections to ensure compliance with Good Manufacturing... Read More
For drug registration in China, required documentation includes a comprehensive dossier with clinical trial data, quality control standards, manufacturing processes, stability studies, pharmacological and toxicological reports, and proof of Good Manufacturing Practice (GMP) compliance. Additionally, a Certificate of Pharmaceutical Product (CPP) and... Read More